John A. Roush
Analyst · CJS Securities
Thank you, Tim. Good afternoon, everybody. Welcome to our call. And thank you for your continued interest in the company.
So as we report our second quarter results, I’ll say that, it was a challenging quarter in that, on the one hand, the company did execute very well against the agenda that we had laid out for ourselves, and we are proud of what we accomplished with that. But on the other hand, the market environment that emerged during the second quarter, late in the quarter was a major disappointment to us, and it has had an impact on our results and our outlook.
So as you take a look at our numbers, it’s important for you to note a few key things. First, if you’ve had a chance to look at our press release, you’ll see that we moved our semiconductor systems and laser systems businesses to discontinued operations. This obviously does change the baseline level of our numbers, and we’ll be commenting about that in some detail on this call.
The use of the discontinued operations treatment beginning this quarter reflects the fact that our divestiture processes were far enough along at quarter-end that this accounting treatment was appropriate. The second thing you’ll note, as I mentioned, is that our results were impacted by a sudden and significant deterioration in market demand during the quarter.
At the end of the first quarter and into the first 2 months of the second quarter, we had experienced very strong order rates and encouraging signs of recovery in most of our lines of business. However, towards the end of May, we saw order rates significantly deteriorate, first in Europe, then in China. The sudden decline in our OEM customer demand was linked to significant drops in manufacturing activity, which impacted both our industrial and microelectronics markets, as well as some delays in government research funding, which impacted our scientific laser business.
The magnitude of these changes was not originally contemplated in our revenue and earnings guidance. However, despite this weakness, we were able to deliver within our original guidance range, achieving approximately $86 million in sales and over $13 million of EBITDA when adding back to results of our now discontinued operations to make a valid comparison of actual results versus our guidance.
We also finished the second quarter with our cash position exceeding our debt balance by $3 million, which was also in line with our expectations. While we are disappointed in the suddenness and the severity of the market slowdown, it really doesn’t deter us from vigorously driving forward with our agenda for the company. In fact, my view is that the actions we have undertaken across GSI will position us more effectively to cope with this type of market turbulence in the future.
During the quarter, we also made significant progress on reducing our operating complexity and our breakeven point. We are on track with virtually every element of the 12x12 restructuring program that began in the fourth quarter of 2011. Since the announcement of this program, we have eliminated 2 sales and service centers in Japan, relocated our scientific laser production activities in East Setauket, New York to Santa Clara, California, closed our optics production facility in Oxnard, California, put our sales and service office in Mumbai, India up for sale; launched the consolidation of our sales and service offices in Germany, and have made significant progress in the consolidation of our Lexington, Massachusetts operations into our Bedford, Massachusetts facility.
We remain on track to complete all elements of the 12x12 program by year-end. The other major focus area for us is the strategic positioning and the growth potential of our portfolio. Our agenda here is to focus organic growth and acquisition efforts on several key growth platforms. Those would be fiber lasers, scanning solution and medical components as discussed on previous calls, and also, to exit our systems businesses.
Taken together, these moves will definitely take us in the direction of being a higher growth and more stable company. The transformation of our portfolio is not something that can happen in a quarter or 2. As we sit here today, we still have a company with a level of volatility or economic sensitivity that’s higher than we like, but in fact, we are making very good progress on our organic growth investments, as well as our potential acquisition.
In terms of second quarter revenue, we delivered $70 million on a continuing operations basis, with a book-to-bill ratio of 1.0. We did have a number of businesses that saw strong revenue in the quarter despite the weak overall market. Our fiber lasers business saw revenues more than tripled from a year ago with a book-to-bill ratio of 1.7. Our scanning solutions business grew 15% year-over-year with a book-to-bill ratio of 1.6. Our optical encoder business grew 25% and our color measurement business grew mid-teens percentage on a year-over-year basis.
So despite the overall weakness in demand, we were pleased that we saw strength in areas where we have been specifically investing to drive growth. From an end market perspective, we saw our microelectronics business decline 29% year-over-year. Scientific was down 25%, industrial was down 7%, and medical was down just 3%, primarily due to a little bit of weakness in Europe, but grew in other geographies.
In terms of profitability, on a continuing operations basis, we had second quarter adjusted EBITDA of $12 million, which is 17% of sales. We are managing our discretionary expenses very carefully at this stage, and we are pleased with our level of profitability given that our sales outlook dropped on the order of $6 million within the quarter itself.
Despite the weak market conditions, the company executed well on a number of fronts in the quarter. From an organizational perspective, we made several key hires that will strengthen our capability. We brought on board a corporate development leader with a strong background in both investment banking at Morgan Stanley and business development at Boeing. We also hired a corporate leader for our companywide continuous improvement programs, an individual with 20 years of operations and continuous improvement experience, including a 12-year tenure with Danaher.
We also hired a Site Operations Leader for our Massachusetts-based operation, an individual who has an extensive background of operations and leadership with Ingersoll Rand, GE, and International Paper. These leaders bring significant talents and capabilities to the organization that will help to make GSI a stronger company for years to come.
We also had 3 new directors join our board during the quarter. Harry Bosco, who was serving as CEO of Opnext prior to their acquisition by Oclaro, joined the board and brings extensive leadership experience in technology businesses.
In addition, Dom Romeo who served as CFO of IDEX Corporation for 7 years joined our board. Dom was instrumental in the transformation of that company and previously played senior financial leadership roles in AlliedSignal, Honeywell, and several other companies.
Finally, Tom Secor joined the board. Tom previously spent 5 years with Goldman Sachs and brings to our board an extensive background in finance and legal matters. And all 3 of the new directors served on additional outside boards. Finally, as we spoke about in prior earnings releases, acquisitions remain an important part of our growth strategy. During the quarter, we continued to develop our strategic roadmap and as part of that we have cultivated a significant pipeline of potential acquisitions.
For example, we recently completed an in-depth consulting study on the medical components market. This study identified a number of attractive market adjacencies and potential acquisition targets.
Now that we have a strong Corporate Development leader on board, we are better positioned to drive these deals forward. As we are increasing our acquisition focus, we remain disciplined in our approach with respect to strategic fit, valuation, and multiples, but improving the portfolio is an important part of our strategy and acquisitions will play a key role. We now have a number of attractive targets in discussion, and we remain confident we will be successful in executing on this element of our strategy.
So with that, I’ll now turn it over to Robert Buckley to provide some more details on the financials. Robert?